Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
about
sameAs
Economic considerations in the management of Alzheimer's diseaseCognitive rehabilitation combined with drug treatment in Alzheimer's disease patients: a pilot studyPsychological treatments for depression and anxiety in dementia and mild cognitive impairmentPsychological treatments for depression and anxiety in dementia and mild cognitive impairmentAlzheimer disease: new concepts on its neurobiology and the clinical role imaging will playThe use of herbal medicine in Alzheimer's disease-a systematic reviewPractical diagnosis and management of dementia due to Alzheimer's disease in the primary care setting: an evidence-based approachGoing beyond antidepressant monotherapy for incomplete response in nonpsychotic late-life depression: a critical reviewThe potential role of non-steroidal anti-inflammatory drugs in treating Alzheimer's diseaseAlzheimer's disease: current pharmacotherapy in the context of patient and family needs.Long-Term Cholinesterase Inhibitor Therapy for Alzheimer's Disease: Practical Considerations for the Primary Care PhysicianTreatment guidelines for Alzheimer's disease: redefining perceptions in primary care.Assessment and treatment of nursing home residents with depression or behavioral symptoms associated with dementia: a review of the literature.Nimodipine improves regional cerebral blood flow and suppresses inflammatory factors in the hippocampus of rats with vascular dementia.People with Parkinson's disease and normal MMSE score have a broad range of cognitive performanceA randomized trial of the impact of a specific care plan in 1120 Alzheimer's patients (PLASA Study) over a two-year period: design and baseline data.Cholinesterase inhibitors: drugs looking for a disease?Validation of the Cognitive Assessment of Later Life Status (CALLS) instrument: a computerized telephonic measure.The process of definitive institutionalization of community dwelling demented vs non demented elderly: data obtained from a network of sentinel general practitioners.Safety and tolerability of rivastigmine transdermal patch compared with rivastigmine capsules in patients switched from donepezil: data from three clinical trials.Alzheimer DiseaseThe effect of APOE ε4 allele on cholinesterase inhibitors in patients with Alzheimer disease: evaluation of the feasibility of resting state functional connectivity magnetic resonance imaging.Second-generation antipsychotics in dementia: beyond safety concerns. A clinical, systematic review of efficacy data from randomised controlled trials.Early intervention in Alzheimer's disease: a health economic study of the effects of diagnostic timing.Ethnic differences in acetylcholinesterase inhibitor use for Alzheimer diseaseRecent cerebrospinal fluid biomarker studies of Alzheimer's disease.Update on the pharmacological treatment of Alzheimer's diseaseThe Effectiveness of Dance Interventions to Improve Older Adults' Health: A Systematic Literature Review.Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study.Optimal management of Alzheimer's disease patients: Clinical guidelines and family advice.Effectiveness of a specific care plan in patients with Alzheimer's disease: cluster randomised trial (PLASA study)The art of sharing the diagnosis and management of Alzheimer's disease with patients and caregivers: recommendations of an expert consensus panelCholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials.The effect of therapeutic touch on pain and fatigue of cancer patients undergoing chemotherapy.Treating patients with moderate to severe Alzheimer's disease: implications of recent pharmacologic studies.Quality of dementia clinical guidelines and relevance to the care of older people with comorbidity: evidence from the literatureTreatment of cognitive, psychiatric, and affective disorders associated with Parkinson's disease.Alzheimer disease therapeutics.Errorless practice as a possible adjuvant to donepezil in Alzheimer's disease.The costs of caring: medical costs of Alzheimer's disease and the managed care environment.
P2860
Q22241448-EA49692B-CAFC-4ACA-A491-BA6A8C35731EQ22241713-8A31034C-3B3C-47CC-A917-0C6F6DBAF125Q24201053-9EF8F218-0C6B-47A7-9924-0E839EAFB72EQ24235018-0EAF7DCA-5F7A-4FE4-954B-68A6DC4D82F3Q24594531-22534A05-B371-4CF3-9E02-241C3CF8D810Q24673334-055D41A7-3130-4B56-93CD-70551EA80D57Q27006895-AC93822E-C1A2-48B9-978C-26C7430F0F61Q27022958-EC95A3F7-D4ED-47AC-A44B-5DFE911D1636Q28171273-38B83F3F-44D4-45DD-86C2-0CE7ED464903Q30310930-AE99BAAD-61A2-4C0A-AAEB-6AEE8AA1E47EQ30433785-66FC3C9C-4BC6-4D54-9993-EA415C497C69Q30443975-1E90EC17-BDC0-453E-BB1E-7A308BC81CEDQ30540486-F0A0098F-96C2-4F7E-A1F5-FA0C8A1521CBQ30558416-FE3BCB0D-A119-48D0-AF71-690F0AC7FDD1Q30586896-80FB8A97-5B30-40AC-9418-DAFDE64DBCB4Q31150911-47A13439-F9B9-429B-9DEC-53CF3D062E69Q33238993-CC91075A-067D-44FC-865A-0C0100BB0C4EQ33285310-F01AD485-C240-42CD-99E4-C22E20B38F51Q33378601-2CBA351A-F015-4A62-9A71-5F78FAAE935CQ33525354-9A213F59-4AF8-461D-B880-B5F0C836333BQ33562441-6D97018F-BB87-4492-9A01-6B795304E38BQ33624389-EF3AE4F3-0D73-4AAA-AA23-BF2CAA22E15AQ33641585-9FD299D9-1BCC-4EFD-9EFE-2DBA637F5827Q33656133-A496A68A-A3A4-4D27-9A2B-B0B45B8E4C70Q33697895-EE440BC9-7315-4C97-A215-209B3D72F353Q33766323-B5413C6C-442B-4576-B076-4F7DBDDE96BCQ33836947-D42C7BBA-7553-4BB8-8066-BAFB77C6DC7EQ33854002-4781708A-E37A-4B32-A534-D8D4B10E0095Q33869831-B0400C7D-C13D-43C4-B6C9-B4D76FC9EA64Q33881534-DD0FA070-ED13-43EE-BF33-5092B19D2001Q33895643-3AF71ECA-4490-4880-9354-7B315B9F2E95Q33902284-1105DF5E-F4C6-4B77-B514-9559AA950B61Q33912750-B9E3A17F-9126-47F8-9D83-C08E3F2F99DEQ33919723-93A083E2-8973-4D97-95EE-24AD16C764B9Q33928316-7B83B8C6-A1F3-449D-BF8F-9D1F51809A32Q34090081-90E8462A-5C13-48E3-82BD-5A500CE85BB0Q34388686-D4091FA4-B60B-40FE-BC08-416C944DCE79Q34393812-2BF07196-9E7B-4D00-BFA9-E5532D9D76AAQ34443767-57E2552A-9E01-4D3E-9224-0BF99E236E2FQ34496154-7270654B-A21F-4499-84FD-F762A98CA324
P2860
Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Practice parameter: Management ...... American Academy of Neurology
@ast
Practice parameter: Management ...... American Academy of Neurology
@en
Practice parameter: Management ...... American Academy of Neurology
@en-gb
type
label
Practice parameter: Management ...... American Academy of Neurology
@ast
Practice parameter: Management ...... American Academy of Neurology
@en
Practice parameter: Management ...... American Academy of Neurology
@en-gb
altLabel
Practice parameter: management ...... American Academy of Neurology.
@ast
Practice parameter: management ...... American Academy of Neurology.
@en
prefLabel
Practice parameter: Management ...... American Academy of Neurology
@ast
Practice parameter: Management ...... American Academy of Neurology
@en
Practice parameter: Management ...... American Academy of Neurology
@en-gb
P2093
P356
P1433
P1476
Practice parameter: Management ...... American Academy of Neurology
@en
Practice parameter: management ...... American Academy of Neurology.
@en
P2093
Cummings JL
DeKosky ST
Dubinsky RM
J.C. Stevens
J.L. Cummings
P304
P356
10.1212/WNL.56.9.1154
P407
P577
2001-05-01T00:00:00Z
2001-05-08T00:00:00Z